CETX Q3 2024 Earnings Deep EPS Miss Raises Concerns Amid Operational Challenges MRCC Q4 2025 Earnings EPS Surges Past Estimates with 1983 Beat Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress IMMP Q1 2026 Earnings EPS Misses Estimates But Positive Clinical Momentum Lifts Stock PTGX Q1 2026 Earnings Surprise Profitability Defies Estimates Amid No Revenue PMVP Q1 2026 Earnings Narrower Loss Slightly Beats Estimates as Development Advances